$BeyondSpring(BYSI.US$ Brothers and Sisters, let's not be discouraged right now, read up CCXI May 7 when they FDA got rejected too,share plummeted 59%.but they appeal,they resubmit mire datas, they got it approved in october.
Let's just wait for the news release from company, i think the docs n researchers are not so dumb to submit something that will deemed failure to FDA. They worked years on plinabulin just like CCXI on their Avacopan.
Let's just wait for the news release from company, i think the docs n researchers are not so dumb to submit something that will deemed failure to FDA. They worked years on plinabulin just like CCXI on their Avacopan.
6
3
$BeyondSpring(BYSI.US$
please let there be some good news in 2022
please let there be some good news in 2022
4
$ChemoCentryx(CCXI.US$
$NIO Inc(NIO.US$
$Meta Platforms(FB.US$
$Altimeter Growth Corp(AGC.US$
$Advanced Micro Devices(AMD.US$
can someone enlighten me what just happen same trend suddenly all go down.. all my greens become sea of red
$NIO Inc(NIO.US$
$Meta Platforms(FB.US$
$Altimeter Growth Corp(AGC.US$
$Advanced Micro Devices(AMD.US$
can someone enlighten me what just happen same trend suddenly all go down.. all my greens become sea of red
47
18
23
5
3
1
2
2
Butterfly_Effect OP : i am aware CRL and extension(CCXI) is a different thing, but i too read up that CRL allows for appeal. worst case scenario BYSI did not put up an appeal but in their pipeline they have FDA china approval and also 3rd phrase completed for NSCLC and other medicines,hence a CRL on their CIN is no doubt devastating but it shouldn't be a death sentence for BYSI. it's just my tots on this plummet I'm stucked too at 13.80 with nomore bullets to average down.